← 返回

过继转移的肿瘤特异性产 IL-9 细胞毒性 CD8(+) T 细胞激活宿主 CD4(+) T 细胞以控制抗原丢失的肿瘤

英文原题:Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8(+) T cells activate host CD4(+) T cells to control tumors with antigen loss.

查看英文原题

Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8(+) T cells activate host CD4(+) T cells to control tumors with antigen loss.

PubMed 2025/04/03(内容时间) Nat Cancer Q1 · IF 28(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

宿主效应CD4 + T细胞成为肿瘤消退的关键介质,但它们能否被过继转移的CD8 + T细胞激活仍不清楚。我们此前报道,过继转移产生白细胞介素9(IL-9)的细胞毒性CD8 + T(Tc9)细胞可实现肿瘤生长的长期控制。在此,我们证明小鼠肿瘤特异性Tc9细胞通过招募并激活宿主效应CD4 + T细胞来控制抗原丢失复发肿瘤的生长。Tc9细胞分泌IL-24,并将表达CCR7的常规2型树突状细胞(cDC2细胞)招募至肿瘤引流淋巴结,以启动宿主CD4 + T细胞对抗复发肿瘤。宿主CD4 + T细胞或cDC2缺陷会损害Tc9细胞控制复发肿瘤生长的能力。此外,在人类癌症中,瘤内IL24表达与cDC2和CD4 + T细胞基因特征相关,且其表达与患者更好的生存相关。本研究报道了一种在体内激活肿瘤特异性CD4 + T细胞的机制。

展开英文摘要原文

Host effector CD4 + T cells emerge as critical mediators for tumor regression but whether they can be activated by adoptively transferred CD8 + T cells remains unknown.

We previously reported that adoptive transfer of interleukin 9 (IL-9)-producing cytotoxic CD8 + T (Tc9) cells achieved long-term control of tumor growth.

Here, we demonstrate that murine tumor-specific Tc9 cells control the outgrowth of antigen-loss relapsed tumors by recruiting and activating host effector CD4 + T cells. Tc9 cells secreted IL-24 and recruited CCR7-expressing conventional type 2 dendritic cells (cDC2 cells) into tumor-draining lymph nodes to prime host CD4 + T cells against relapsed tumors. Host CD4 + T cell or cDC2 deficiency impaired the ability of Tc9 cells to control relapsed tumor outgrowth.

Additionally, intratumoral IL24 expression correlates with cDC2 and CD4 + T cell gene signatures in human cancers and their expression is associated with better patient survival.

This study reports a mechanism for activation of tumor-specific CD4 + T cells in vivo.

论文信息

作者
Xiao L、Duan R、Liu W、Zhang C、Ma X、Xian M、Wang Q、Guo Q
第一作者单位
Houston Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX, USA. xiaoliuling@cqmu.edu.cn.United States
通讯作者单位
Houston Methodist Neal Cancer Center, Houston Methodist Research Institute, Houston, TX, USA. qyi@houstonmethodist.org.United States
期刊
Nature cancer2025 Apr
原文标识
PubMed 40181089 · DOI 10.1038/s43018-025-00935-0